XML 15 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Financial Data (Tables)
12 Months Ended
Sep. 30, 2012
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Data
(in thousands, except per common share data)
 
Quarter ended
 
Dec. 31
 
March 31
 
June 30
 
Sept. 30
Fiscal 2012
 
 
 
 
 
 
 
Net sales
$
46,662

 
$
49,016

 
$
47,632

 
$
47,248

Gross profit
24,430

 
25,783

 
25,304

 
24,820

Net income (1)(2)
724

 
2,122

 
2,307

 
2,462

Net income per common share - basic
0.03

 
0.08

 
0.09

 
0.10

Net income per common share - diluted
0.03

 
0.08

 
0.09

 
0.09

 
 
 
 
 
 
 
 
Fiscal 2011
 
 
 
 
 
 
 
Net sales
$
48,334

 
$
49,716

 
$
54,274

 
$
51,836

Gross profit
24,666

 
25,651

 
28,755

 
27,516

Net income (1)(2)
2,316

 
2,239

 
3,615

 
2,849

Net income per common share - basic
0.09

 
0.09

 
0.14

 
0.11

Net income per common share - diluted
0.09

 
0.09

 
0.14

 
0.11

(1)
During fiscal 2012 and 2011, we recorded discrete tax benefits of $1.5 million and $0.7 million, respectively. We recorded a benefit of $0.1 million in the first quarter of fiscal 2012 resulting from the release of income tax reserves due to the expiration of the statutes of limitations from various U.S. tax jurisdictions. During the third quarter of fiscal 2012, we recorded $1.1 million for additional research and development tax credits identified for fiscal years ended September 30, 2009, 2010 and 2011 from a recently completed research and development tax credit study. During the fourth quarter of fiscal 2012, we recorded $0.3 million relating to expiration of statue of limitations. During fiscal 2011, we recorded $0.6 million in the first quarter and $0.1 million in the fourth quarter resulting from the reversal of previously established income tax reserves from various jurisdictions, primarily foreign, for the expiration of statute of limitations and from the enactment of the Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010 providing for the extension of the research and development tax credit.
(2)
During fiscal 2012, we recorded a business restructuring accrual of $0.2 million ($0.2 million after tax) in the first quarter, $0.1 million ($0.0 million after tax) in the second quarter and $1.0 million ($0.6 million after tax) in the third quarter. We reversed a business restructuring accrual of $0.1 million ($0.0 million after tax) in the first quarter of fiscal 2011 and recorded a restructuring charge of $0.2 million ($0.1 million after tax) during the fourth quarter of fiscal 2011.